HALOZYME THERAPEUTICS INC shareholders Q2 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,323,512$155,949,0783.32%
Future Fund LLC 9,162$330,4733.14%
Steamboat Capital Partners, LLC 193,245$6,970,3472.40%
BERNZOTT CAPITAL ADVISORS 304,009$10,965,6052.37%
2Xideas AG 645,288$23,275,5382.23%
Redwood Investments, LLC 432,881$15,614,0181.91%
First Light Asset Management, LLC 584,248$21,073,8251.65%
Mesirow Institutional Investment Management, Inc. 422,712$15,247,2221.57%
HighMark Wealth Management LLC 41,790$1,507,3651.13%
EFG Asset Management (North America) Corp. 141,581$5,106,8271.10%
Granite Investment Partners, LLC 758,118$27,345,3161.09%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 95,500$3,443,7301.05%
Penn Capital Management Company, LLC 286,490$10,333,6941.00%
SHAKER INVESTMENTS LLC/OH 53,152$1,917,1930.98%
MIZUHO MARKETS AMERICAS LLC 402,783$14,528,3830.95%
DOHENY ASSET MANAGEMENT /CA 29,250$1,0550.90%
SECTORAL ASSET MANAGEMENT INC 139,437$5,029,4930.84%
TEALWOOD ASSET MANAGEMENT INC 46,685$1,6840.82%
GW&K Investment Management, LLC 2,379,589$85,8310.81%
Stephens Investment Management Group LLC 1,339,122$48,302,1310.75%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.